关键词: Acquired immune deficiency syndrome Chylous ascites Efavirenz Fungal sepsis Penicillium marneffei Voriconazole

Mesh : AIDS-Related Opportunistic Infections / diagnosis drug therapy Acquired Immunodeficiency Syndrome / complications drug therapy microbiology Alkynes Amphotericin B / pharmacology Anti-Retroviral Agents / therapeutic use Antifungal Agents / pharmacology Benzoxazines / therapeutic use Chylous Ascites / complications drug therapy microbiology Cyclopropanes Diagnosis, Differential Humans Male Middle Aged Mycoses / drug therapy Penicillium / drug effects metabolism Pyrimidines / pharmacology Sepsis / drug therapy Triazoles / pharmacology Voriconazole

来  源:   DOI:10.3748/wjg.v18.i37.5312

Abstract:
Penicillium marneffei (P. marneffei) infection usually occurs with skin, bone marrow, lung or hepatic involvement. However, no cases of P. marneffei infection with chylous ascites have been reported thus far. In this report, we describe the first case of acquired immune deficiency syndrome (AIDS) which has been complicated by a P. marneffei infection causing chylous ascites. We describe the details of the case, with an emphasis on treatment regimen. This patient was treated with amphotericin B for 3 mo, while receiving concomitant therapy with an efavirenz-containing antiretroviral regimen, but cultures in ascitic fluid were persistently positive for P. marneffei. The infection resolved after treatment with high-dose voriconazole (400 mg every 12 h) for 3 mo. P. marneffei should be considered in the differential diagnosis of chylous ascites in human immunodeficiency virus patients. High-dose voriconazole is an effective, well-tolerated and convenient option for the treatment of systemic infections with P. marneffei in AIDS patients on an efavirenz-containing antiretroviral regimen.
摘要:
暂无翻译
公众号